Details for New Drug Application (NDA): 205181
✉ Email this page to a colleague
NDA 205181 describes BUTENAFINE HYDROCHLORIDE, which is a drug marketed by Taro and is included in one NDA. It is available from twelve suppliers. Additional details are available on the BUTENAFINE HYDROCHLORIDE profile page.
The generic ingredient in BUTENAFINE HYDROCHLORIDE is butenafine hydrochloride. There are two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.
The generic ingredient in BUTENAFINE HYDROCHLORIDE is butenafine hydrochloride. There are two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.
Summary for 205181
| Tradename: | BUTENAFINE HYDROCHLORIDE |
| Applicant: | Taro |
| Ingredient: | butenafine hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 205181
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BUTENAFINE HYDROCHLORIDE | butenafine hydrochloride | CREAM;TOPICAL | 205181 | ANDA | Walgreen Company | 0363-2100 | 0363-2100-02 | 1 TUBE in 1 CARTON (0363-2100-02) / 30 g in 1 TUBE |
| BUTENAFINE HYDROCHLORIDE | butenafine hydrochloride | CREAM;TOPICAL | 205181 | ANDA | Walgreen Company | 0363-2101 | 0363-2101-08 | 1 TUBE in 1 CARTON (0363-2101-08) / 12 g in 1 TUBE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | CREAM;TOPICAL | Strength | 1% | ||||
| Approval Date: | Nov 16, 2017 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
